Crossject SA is an emerging specialty pharmaceutical company based in France and the U.S. that focuses on advanced regulatory and needle-free injection technologies. Headquartered in Dijon, France, the firm develops innovative drug delivery systems.
Subscribe to see CROSSJECT’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CROSSJECT is a pharmaceuticals company headquartered in France. Xcout tracks 6 named people at CROSSJECT, including Didier Morin (Executive Officer).
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.